Last reviewed · How we verify

NCT05883215

Effects of Social Media Usage on Pain Catastrophizing and Disease Impact in Female Patients With Fibromyalgia Syndrome

Status unknown Last updated 31 May 2023
What this trial tests

trial testing Pain catastrophizing scale in Fibromyalgia in 73 participants. Status unknown.

Timeline
1 October 2023
Primary endpoint
1 June 2024
1 December 2024

Quick facts

Lead sponsorUskudar State Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment73
Start date1 October 2023
Primary completion1 June 2024
Estimated completion1 December 2024

Drugs / interventions tested

Conditions studied

Sponsor

Uskudar State Hospital

Who can join

Adults 18 to 65, female only, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effects of social media usage on pain catastrophizing and disease impact in female individuals diagnosed with fibromyalgia syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pain catastrophizing scale

Trials testing the same drug.

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Uskudar State Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05883215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing